RegeneRx Biopharmaceuticals Inc Share Price OTC Bulletin Board
Equities
Pharmaceuticals
Sales 2021 | 76.76K 6.41M | Sales 2022 | 76.76K 6.41M | Capitalization | 19.94M 1.66B |
---|---|---|---|---|---|
Net income 2021 | -1M -83.46M | Net income 2022 | -1M -83.46M | EV / Sales 2021 | 298 x |
Net cash position 2021 | 66.69K 5.57M | Net Debt 2022 | 1.16M 96.43M | EV / Sales 2022 | 275 x |
P/E ratio 2021 |
-13.9
x | P/E ratio 2022 |
-11.5
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 55.86% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 86 | 13/82/13 | |
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01/84/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01/84/01 |
Founder | 86 | 13/82/13 | |
Joe McNay
BRD | Director/Board Member | 90 | 01/02/01 |
1st Jan change | Capi. | |
---|---|---|
-3.89% | 88.14B | |
+1.45% | 40.51B | |
-14.71% | 31.67B | |
+51.20% | 24.62B | |
-15.11% | 15.65B | |
-13.99% | 12.07B | |
-7.87% | 11.97B | |
-39.40% | 11.61B | |
+5.62% | 8.81B |